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PURPOSE. To investigate longitudinal changes in goblet cell density (GCD) in contact lens (CL)
wearers who do and do not develop symptoms of dry eye (DE).
METHODS. Sixty healthy individuals fitted with daily disposable hydrogel CLs and 23 age-
balanced non-CL–wearing controls underwent assessment using the 5-item dry eye
questionnaire, noninvasive tear film break-up time measurement, ocular surface assessment,
and phenol red thread test evaluation. Laser scanning confocal microscopy (LSCM) and
conjunctival impression cytology (CIC) were used to assess GCD at baseline and follow-up
visits at 1 week and 1 and 6 months. After 1 week, all CL wearers were categorized as those
who were and were not symptomatic based on responses to the CL dry eye questionnaire-8
(CLDEQ-8). A linear mixed-model was used to examine changes in GCD over time.
RESULTS. The global mean GCD of the 83 participants at baseline (before CL wear) was 4766 41
and 4676 52 cells/mm2 using LSCM and CIC, respectively. After 6 months of CL wear, GCD was
reduced by approximately 13% and 29% in asymptomatic (N ¼ 29) and symptomatic (N ¼ 17)
CL wearers (all P < 0.001), respectively, observed with both LSCM and CIC.
CONCLUSIONS. Contact lens wear induces a reduction of GCD over 6 months, which is
exacerbated in those with DE symptoms. Either LSCM or CIC can be used to assess GCD in
the conjunctiva.
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Conjunctival goblet cells (GCs) are secretory epithelial cellsresponsible for the production of the mucinous compo-
nent of the tear film to support the integrity of the ocular
surface. A decreased number of GCs is common in conditions
of dry eye (DE),1,2 which is described as a multifactorial
disorder causing damage to the ocular surface.3 Goblet cells
may also contribute to the ocular immune response, as they
have been shown to secrete cytokines and modulate dendritic
cell phenotype.4 The presence of mucin during contact lens
wear (CLW) promotes surface wettability and tolerance to CLW.
However, a lack of mucin discharge onto the ocular surface can
cause the patient to experience symptoms such as itching,
burning, reduction of visual acuity, and dryness.5
Contact lens (CL) wearers frequently report symptoms of
dryness but the reason for this is not completely understood.
The resulting discomfort may cause CL wearers to reduce
wearing time, or cease lens wear altogether. Indeed, up to 50%
of wearers will discontinue CLW permanently due to DE
symptoms.6 It is therefore important to understand whether
CLW causes a reduction in GCD in those who are introduced to
CLW and to determine the link between GCD and DE
symptoms related to CLW.
Reports of the impact of CLW on conjunctival GCD are
equivocal, perhaps as a result of methodologic differences in
using conjunctival impression cytology (CIC) to determine
GCD. The time-course of changes to GCD as a result of CLW is
also unclear.
Conjunctival samples obtained using CIC can be assessed
using flow cytometry and polymerase chain reaction, allowing
mucin-type material to be analyzed, and mRNA expression of
specific MUC genes to be quantified. Due to the invasive, time-
intensive, and laboratory-based nature of CIC, in vivo laser
scanning confocal microscopy (LSCM) may represent an
alternative and fundamentally advantageous approach for
morphologic assessment of cells at the ocular surface.
The aim of this study is to determine longitudinal changes in
GCD in those with and without CL-induced DE symptoms,
using both CIC and in vivo LSCM. A secondary aim of this study
is to determine whether in vivo LSCM could essentially replace
CIC for assessing GCD. This work could help researchers and
practitioners better understand the importance of GCs and the
role they play in CL comfort.
METHODS
Study Design and Participants
This was a prospective, longitudinal, observational, case-
controlled clinical study. Ethical clearance was provided by
the Queensland University of Technology Research Ethics
Committee (Kelvin Grove, Australia) and written informed
consent was obtained from all participants prior to enrollment.
The research was conducted in accordance with the principles
of the Declaration of Helsinki.
Potential participants interested in wearing daily disposable
CLs (details below) were recruited from the staff and student
population of the Queensland University of Technology,
Brisbane, Australia. Individuals were not eligible if they had
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worn CLs during the 6 months prior to enrollment, current
pregnancy, ocular trauma or surgery, ocular surface dysfunc-
tion, current classification as symptomatic for DE based on
answers to the DE questionnaire 5 (DEQ-5),7 current or long-
term use of topical ocular medication, or ocular or systemic
disease that may affect the conjunctiva. Additional exclusion
criteria for the CL-wearing group were astigmatism of more
than 1.50 diopters (D), myopia more than 7.00 D, and
hyperopia more than þ2.00 D.
Participants assigned to wear CLs were fitted with
‘Biomedics 1 day Extra’ daily disposable CLs (CooperVision,
Pleasanton, CA, USA). These lenses are made from the hydrogel
material ‘ocufilcon D’ and had the following parameters and
characteristics: water content 55%, diameter 14.2 mm, base
curve 8.6 or 8.8 mm, center thickness (at 3.00 D) 0.07 mm,
power range 10.00 D to þ6.00 D, oxygen permeability (Dk)
19 3 1011 cm2 mlO2/s mL mm Hg, oxygen transmissibility
(Dk/t; at3.00 D) 273 109 cm mlO2/s mL mm Hg, and light
blue handling tint.
Lenses were worn on a daily wear basis and all lens wearing
participants as well as a group of age-balanced controls
underwent detailed assessment of DE signs and symptoms
over a 6-month period. Validated DE questionnaires7,8 (DEQ-5
for controls and CLDEQ-8 for CL wearers) were applied and all
participants also underwent DE tests and GCD assessment
using LSCM and CIC at baseline, 1 week, and 1 and 6 months.
The testing procedures using both techniques were conducted
by two experienced examiners (L.H.C. doing CIC and Y.A.
doing LSCM) who were masked as to the group assignment of
participants. All the tests were performed between 7 AM and
12 PM.
Dry Eye and Ocular Surface Assessment
Symptoms and signs of DE were assessed during recruitment in
order to exclude individuals with this condition. Symptoms
were determined using the DEQ-5 questionnaire and DE signs
assessed by noninvasive break-up time (NIBUT),9 phenol red
thread (PRT),10 and ocular surface assessment (OSA).11 To be
considered eligible for this study, participants were required to
pass the DEQ-5 and at least one of the objective DE tests,
according to the pass/fail scores shown in Table 1. The
methods used during this study to assess DE and ocular surface
staining have been reported in detail elsewhere14 and are
briefly described in Table 1.
After 1 week of CLW, the CLDEQ-8 was used to differentiate
those in the CL-wearing group as either symptomatic or
asymptomatic for CL-induced DE. The subjective (CLDEQ-8)
and objective (NIBUT, PRT, or OSA) DE tests were repeated at 1
and 6 months. All tests were performed a few minutes after CL
removal.
Goblet Cell Density
In Vivo Laser Scanning Confocal Microscopy. Con-
junctival LSCM was performed using the Heidelberg Retinal
Tomograph (HRT3) equipped with a Rostock Corneal Module
(Heidelberg Engineering GmbH, Heidelberg, Germany). One
eye was anaesthetized with 0.4% oxybuprocaine hydrochloride
(Chauvin Pharmaceuticals Ltd., Surrey, UK). The participant
was instructed to direct their gaze opposite to the region of
measurement. The center of the surface of the TomoCap was
positioned on the conjunctiva approximately 2 to 4 mm from
the limbus.
Goblet cells at the nasal bulbar conjunctiva were scanned
while focusing the applanating lens at approximately three
different depths, using a 400 3 400 lm2 sampling area. As
reported previously, a minimum of 11 images are necessary to
determine the average GCD with an acceptably low variance15;
thus, 11 images were selected from the 30 captured images on
each measurement occasion.
Images were selected from LSCM scans that included GCs
identified according to the following features: cell size of 25 to
30 lm in diameter,16,17 hyperreflective,18 bigger than sur-
rounding cells,19 round to oval in shape,20 and sometimes with
a visible nucleus.2
Conjunctival Impression Cytology. A few minutes after
performing LSCM, the same eye was anaesthetized again and
the center of a Biopore membrane (Millicell cell culture inserts;
Millipore Corp, Cork, Ireland) was gently applied to the nasal
bulbar conjunctival surface at approximately 2 to 4 mm from
the limbus. The sample was allowed to air dry and then
immersed in 95% methanol for fixation using a well culture
plate sample holder. The sample was then refrigerated at 48C
for no more than 24 hours.
Giemsa stain was applied according to the following
guidelines from the manufacturer (Sigma-Aldrich, Dorset,
UK). The specimen was allowed to air dry at room
temperature, the Giemsa stain was diluted 1:20 with deionized
water and the specimen was immersed in the diluted Giemsa
solution for 30 minutes. The sample was rinsed with tap water
prior to examination.
A Leica DM2500 microscope (Leica Microsystems, Milton
Keynes, UK) was used to visualize the specimen; this system
TABLE 1. Dry Eye and Ocular Surface Assessment Pass/Fail Scores for Exclusion Due to Dry Eye and Identification of Symptomatic Contact Lens
Wearers
Test Measurement Instrument Method Pass Fail
NIBUT,8 s Tear fluid Keratometer Time from blink to first
mire distortion
‡10 1–9
OSA,9 0–4 Ocular surface integrity Slit-lamp biomicroscope, yellow
observation filter; fluorescein-
impregnated strip; Efron
grading scale for corneal
staining
Estimate corneal staining to
nearest 0.1 grading
increment
0–2 3–4
PRT,10 mm/20s Tear volume Hamano cotton thread tear test Thread in lower lacrimal
river; wetting length
after 20s
‡11 1–10
DEQ-5,7 0–22 Frequency and intensity of
DE symptoms
DEQ-5 questionnaire Score on validated shorter
version of DEQ11
0–6 7–22
CLDEQ-8,12 0–37 DE symptoms in CL wear CLDEQ-8 questionnaire Score on validated shorter
version of CLDEQ13
0–16 17–37
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has a magnification of3200 and field of view of 6403480 lm2.
Approximately 10 images were captured from each sample by
scanning in X and Y directions.
Acceptable images from CIC were those with nondisrupted
cell material that contained GCs approximately 25 to 30 lm in
diameter. The cells had a pale membrane with defined borders
and a visible nucleus localized centrally, although sometimes
eccentrically in bigger cells (approximately 30 lm).21 Goblet
cells were easily differentiated from surrounding cells because
of their balloon-like appearance and size.22 The mean GCD for
each specimen was determined by averaging cell counts
obtained from five of the 10 captured images with non-
disrupted cell material.
The processing of CIC samples and selection of CIC and
LSCM images were carried out by two experienced operators
who were masked as to the group assignment of participants.
Statistical Analysis
The number of participants enrolled into this study was
determined by a sample size calculation23 based on two
previous investigations that used a similar design to the present
work.22,24 We calculated that a minimum sample size of 23
participants was required per group, allowing for 20% attrition.
This analysis gave 90% power, with a type I error of 5% to
detect a difference in GCD between the two groups.
Normality of data was examined using the Shapiro-Wilk test.
Differences in the demographic and clinical characteristics
between the controls and the asymptomatic and symptomatic
CL-induced DE groups were determined for the baseline and
final visits. Dry eye and ocular surface assessments, including
questionnaires, were compared among the controls and the
asymptomatic and symptomatic CL-induced DE groups using
paired and independent sample t-tests. Nonparametric data
were analyzed using v2, Wilcoxon and Mann-Whitney U tests.
All data are presented as mean 6 SD unless otherwise
indicated.
A linear mixed-model (LMM) was applied to examine
changes in GCD of the nasal bulbar conjunctiva over time.
Because changes of GCD in CLW over time was the main
parameter of interest of this study, GCD was considered the
response variable and time was added to the model to test the
linear effect of CLW on GCD. The model contained GCD as the
response variable. The primary fixed effects of interest were:
group (i.e., controls, asymptomatic and symptomatic); test
(i.e., LSCM and CIC); visit (i.e., baseline, 1 and 6 months);
group*visit; and test*visit interactions. Type III sum of square
was selected. Group was included as a time-invariant predictor
to determine group differences over time. Global values of
GCD were used for this analysis (the average of 5 and 11
images for CIC and LSCM, respectively). SPSS for Windows
Version 16 (SPSS Sciences, Chicago, IL, USA) was used for this
statistical analysis and a 2-tailed a ¼ 0.05 level of significance
was applied for all analyses.
RESULTS
A flow diagram showing the number of participants recruited
and enrolled into the study, discontinuing from the study (and
the reasons for this), and finally examined, is presented in
Figure 1. After screening 110 potential study participants, 92
were enrolled into the study. Nine were not assigned to groups
because of failure to attend (four) and CL intolerance (five).
Sixty participants were fitted with CLs and 23 served as
controls. When symptoms of DE were assessed among CL
wearers at the 1-week time-point, the group assignment
comprised 25 participants who were symptomatic and 35
who were asymptomatic. Sixteen participants (8 symptomatic,
6 asymptomatic, and 2 controls) dropped out of the study over
the 24-week study period, leaving 17 symptomatic, 29
asymptomatic, and 21 control participants who completed
the study.
The mean 6 SD lens powers fitted participants were: right
(R) 1.75 6 1.99 D, left (L) 1.64 6 1.80 D for the
symptomatic group and R 1.70 6 1.95 D, L 1.63 6 1.79 D
for the asymptomatic group.
A significant reduction of GCD in the symptomatic and
asymptomatic groups compared with the control group (P <
0.001) was observed. After 6 months of CLW, GCD was
reduced by approximately 13% and 29% in asymptomatic (N¼
29) and symptomatic (N ¼ 17) CL wearers, respectively,
observed with both LSCM and CIC.
The clinical characteristics and demographic data of
participants who did and did not develop CL-induced DE
symptoms after 1 week of CL wear and the controls, at the
baseline and final visits, are presented in Table 2. The baseline
measurements of the questionnaires were considered at 1
week after characterization of the symptomatic and asymp-
tomatic groups among CL wearers. At baseline, before
characterization, the 83 participants (36 males and 47 females)
in the study had a mean age of 30 6 8 years and were age- and
sex-balanced (P ¼ 0.89 and P ¼ 0.22, respectively).
At baseline, the mean DEQ-5 score of the control group was
significantly lower than that for the groups with and without
symptoms of CL-induced DE (P < 0.01). At both the 1-week
and 6-month visits, the CLDEQ-8 score was significantly higher
(~2 times worse) in participants with symptoms compared
with those without symptoms of CL-induced DE (P < 0.001).
No significant difference existed between the three groups in
regard to the NIBUT, OSA, and PRT test (P > 0.17) at baseline.
Sixteen participants discontinued from the study, meaning that
83% of the enrolled participants completed the study. All CL
wearers had refractive errors between 6.75 and þ1.75 D and
astigmatism from 0.25 to 1.25 D.
Contact lens wearing time, as shown in Table 2, after 6-
month wear was not significantly different between symptom-
atic and asymptomatic groups (mean difference 1.5 hours, P¼
0.38). The symptom score (DEQ-5) in the control group was
the same at the baseline and 6-month visit (P¼ 0.64), whereas
in both the symptomatic and asymptomatic groups the CLDEQ-
8 symptom score was lower at the final visit than the baseline
visit (P < 0.001). Noninvasive break-up time was not different
at the final visit compared with baseline for the three groups (P
> 0.10). Ocular surface assessment scores at baseline were
greater at the final visit than at the baseline visit for both the
symptomatic and asymptomatic groups (P < 0.01). A
significant decrease was noted in PRT test values at the final
visit, compared with the baseline visit, for the symptomatic
group versus the control and asymptomatic groups (P <
0.003).
There was more than a 2-fold decrease of GCD at the 1-
week visit in all study participants, observed using both LSCM
and CIC. The reduction of GCD in non-CL wearers is thought
to be an artefact caused by the removal of superficial cell layers
in the nasal bulbar conjunctiva using the CIC technique at
baseline. Therefore, to analyze the longitudinal effect of CLW
on conjunctival GCD, the 1-week visit was removed from the
analysis and LMM was applied. Figure 2 shows the longitudinal
course of GCD over a 6-month period, excluding the 1-week
visit data, assessed with LSCM (Fig. 2A) and CIC (Fig. 2B).
To understand the effect of symptom grouping and time on
the outcome variable, the LMM was applied. The Type III test
of fixed effects shows overall significance for the predictor
variables. There was a significant effect of group and visit;
however, the effect of test (LSCM versus CIC) was not
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TABLE 2. Demographic and Clinical Characteristics of Participants at Baseline and After 6 Months of Contact Lens Wear
Parameter
Baseline Month 6 Follow-up
Control Asymptomatic* Symptomatic* Control Asymptomatic Symptomatic
n (male/female) 23†‡ (19/4) 35† (10/25) 25‡ (7/18) 21jj¶†† (17/4) 29jj (8/21) 17¶ (5/12)
Age 30.0 6 8.0 32.1 6 9.8 28.5 6 6.4 30.3 6 8.0 31.2 6 9.3 28.1 6 5.9
CLW, h – – – – 9.8 6 3.9 8.3 6 3.9
DEQ-5, 0–22 2 6 2†‡ 4 6 2† 4 6 2‡ 2 6 2 – –
CLDEQ-8, 0–37 – 12 6 3§ 21 6 4§ – 11 6 6# 20 6 9#
NIBUT, s 12.7 6 6.1 11.9 6 5.6 13.4 6 5.7 10.0 6 4.3 11.0 6 4.7 9.7 6 5.9
OSA, 0–4 0.5 6 0.6 0.3 6 0.5** 0.4 6 0.5†† 0.3 6 0.4¶ 0.7 6 0.6** 1.0 6 0.8¶††
PRT, mm/20s 22.7 6 8.4 19.9 6 8.0 18.0 6 7.6†† 18.8 6 7.7¶** 16.8 6 8.4# 9.4 6 4.9¶#††
GCD–LSCM, cell/mm2 491 6 43‡ 474 6 40** 466 6 38‡†† 482 6 33¶jj 408 6 50jj#** 335 6 46¶#††
GCD–CIC, cell/mm2 489 6 47† 458 6 55†** 459 6 44†† 457 6 41¶jj 406 6 50jj#** 330 6 64¶#††
* Groups were assigned at 1-week visit.
† P < 0.05, baseline comparison of controls vs asymptomatic.
‡ P < 0.05, controls vs. symptomatic.
§ P < 0.05, asymptomatic vs. symptomatic.
jj P < 0.05, month 6 follow-up comparison of controls vs. asymptomatic.
¶ P < 0.05, month 6 follow-up comparison of controls vs symptomatic.
# P < 0.05, month 6 follow-up comparison of asymptomatic vs. symptomatic.
** P < 0.05, baseline vs month 6 follow-up comparison of asymptomatic.
†† P < 0.05, baseline vs month 6 follow-up comparison of symptomatic.
FIGURE 1. Flow diagram of study.
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significant. The interaction between groups and visits was
significant. No significant interaction existed between test and
visit. Figure 3 shows representative images of the conjunctiva,
using LSCM and CIC, captured from a participant from each
group at the 6-month visit.
A second subset, with restricted maximum likelihood
estimation of fixed-effect parameters for GCD as the continu-
ous response variable, was included in the LMM. In the model,
there was no effect of test (LSCM versus CIC) on GCD (P ¼
0.36); however, there was a significant effect of group (P <
0.001). At the 1-month visit, the interaction between group
and visit was significant for CL wearers compared with
controls (P < 0.05). The LMM also showed a differential effect
of time on GCD, with a decrease of 128 cells/mm2 in
individuals who developed symptoms versus a decrease of 84
cells/mm2 in the asymptomatic group, compared with
controls. There was no effect of test, and the interaction
between test and visit was not significant (P ¼ 0.30).
DISCUSSION
In vivo assessment of conjunctival GCD using LSCM has
emerged as a valuable noninvasive technique that enhances the
investigation of many CL-induced changes in the anterior eye.25
Goblet cell density assessment using LSCM has been used to
assess ocular surface changes related to age,26,27 Sjo¨gren’s
syndrome DE,2,19 pterygium,28 chemical burns,29 glaucoma
treatment with preserved and unpreserved levobunolol,30 and
tafluprost therapy.31 To date, only one cross-sectional report of
GCD assessed by LSCM in CLW has been published, which
showed no significant difference between CL wearers and non-
CL wearers; however, that study was limited by small sample
size.25
Previous longitudinal assessments of GCD in CLW have
been undertaken using in vitro analysis with CIC.24,32–35 The
present study examines, for the first time, longitudinal changes
of GCD in CL wearers using both LSCM and the well-
established CIC technique.
Over a 6-months period, GCD was reduced by approxi-
mately 13% in the asymptomatic and 29% in the symptomatic
group. There was no significant difference between GCD
assessed using LSCM versus CIC over time (P ¼ 0.30). The
control group remained relatively constant over time with a
coefficient of variation of 4% and 7% using LSCM and CIC,
respectively.
The LMM revealed that, regardless of group, the test had no
significant effect on GCD. A test*time interaction term was not
significant (P ¼ 0.30), indicating that the assessment of GCD
using LSCM and CIC did not differ over time regardless of the
changes in GCD.
An additional model was developed in order to determine
longitudinal change only for the control group. The Type III
FIGURE 2. Time course of GCD over a 6-month period, excluding the 1-week visit, in CLW and control groups assessed with (A) LSCM and (B) CIC.
Solid line, control participants; dotted line, asymptomatic CL wearers; dashed line, symptomatic CL wearers. Error bars, mean 6 SD.
FIGURE 3. Representative (A, C, E) CIC and (B, D, F) LSCM images
captured at the 6-month visit. (A) and (B) are from a symptomatic CL
wearer; (C) and (D) are from an asymptomatic CL wearer; and (E) and
(F) are from a non-lens–wearing control participant.
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fixed-effects showed no significant changes from the baseline
to final visit (P ¼ 0.14), suggesting that GCD decreased in the
symptomatic and asymptomatic groups due to the effect of
CLW.
The results of this study disagree with the results from
Connor,32,33 Lievens,34 and Corrales,35 who reported a
statistically significant increase or no changes to GCD assessed
with CIC over a 6-month and 1-year period, in participants
fitted with CLs. This disagreement may be attributed to
variances in the following factors relating to CIC technique:
sample inconsistency across the filter; number of images
sampled; criteria for identifying GCs; quality of acetate filter
used for cell attachment; units used to report GCD; and
conjunctival region assessed. Also, differences in lens-related
factors such as material (e.g., conventional hydrogels versus
silicone hydrogels) and replacement frequency (e.g., daily/
monthly replacement) make it difficult to compare results from
various studies. Few of the previous studies32–34 incorporated a
non-CL wearing control group.
Connor32 reported a 2-fold increase in GCD of 18
participants fitted with 38% water content CLs used on a daily
basis, without CL replacement, initially for 6 months. The same
authors repeated their study 3 years later using a larger sample
size (n ¼ 28) and replaced lenses every 2 weeks (instead of 6
months). The authors found no significant changes from the
baseline to final visit. Lievens et al.34 repeated the study 6 years
later comparing hydrogel and silicone hydrogel lenses worn on
an extended wear basis (6 consecutive days) with weekly and
monthly lens replacement. This study again found a significant
increase in GCD, but no difference between the two groups.
There are further methodologic problems with the three
above-mentioned studies. Only one image per sample was used
to determine GCD. Goblet cell density was expressed as the
percentage of GCs of the total number of cells counted
(including non-GCs) per field of view. In order to have GCs
attach to an acetate filter, the sample must be multilay-
ered.15,21,22 If a multilayered sample is stained with PAS for GC
detection and counter-stained for non-GCs, it is not possible to
undertake a total cell count because there would be two to
three non-GC layers obscuring the view.
In contrast to the above studies, the present findings agree
with the longitudinal findings of Simon et al.,24 who reported a
decrease of GCD after fitting participants with soft and rigid
CLs for 6 months. These authors used CIC and correlated the
severity of symptoms with cytological alterations using a
grading system for squamous metaplasia.24
The findings of this study demonstrate a longitudinal
equivalence between LSCM and CIC. The strengths of this
study are the recruitment of sufficient participants as guided
by power analysis; use of both a noninvasive, reiterative
technique (LSCM) and a gold standard invasive technique
(CIC) to assess GCD; careful phenotyping of symptomatic and
asymptomatic lens wearers; incorporation of a non-CLW
control group; appropriate masking of observers; use of
validated image capture (LSCM) and sample collection (CIC)
protocols; masked image selection and analysis methodology,
and the use of robust statistical modelling.
A general limitation of all studies using CIC is the lack of
evidence relating to the validity of undertaking repeated
measures. We have demonstrated that it may take up to 4
weeks for GCD to recover post-CIC using Biopore Millicell
inserts. The reduction of GCD in non-CL wearers at 1 week is
attributed to an artefact caused by the removal of superficial
cell layers of the epithelium. The conjunctival epithelium is
known to have a rapid healing response, effected by cell
migration and mitosis, whereby normal thickness is restored
within 48 to 72 hours.36 However, the time-course of GC
differentiation, regeneration or migration from inner layers is
unknown. The recovery time for the repopulation of GCs after
having been removed from the conjunctival surface with
different types of acetate filters is also unknown.
The 6-month time frame of this study may have been
insufficient to determine the full extent of changes to GCD in
symptomatic patients. The sex imbalance between groups
limited our ability to draw conclusions regarding gender
differences in CL-induced DE and GCD.
Further studies are required to determine mechanisms of
mucin production and secretion by GCs in relation to DE
symptoms during CL wear. It has recently been demonstrated
that GCs play an important role in the mediation of dendritic
cell phenotype by secreting cytokines.4 New technologies are
needed to fully elucidate functional aspects of conjunctival
GCs and to determine the role of GCs in modulating the ocular
environment in response to external stress such as that
imposed by CLW.
In summary, the results of this study demonstrate that LSCM
has the capability to detect changes of GCD in patients with
CL-induced symptoms of DE. Furthermore, GCD is reduced in
CLW, with the reductions being greater in those who develop
symptoms.
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